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Conclusion: Longer time is needed to corroborate our 
encouraging early results in terms of toxicity, biochemical 
control rates, disease-free survival and overall survival. Our 
report shows that extremely hypofractionated IG-IMRT in 
localized PCa is feasible, safe and well tolerated with good 
PSA response and minimal toxicity. 
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Purpose or Objective: To describe disease control, the 
pattern of failure, laryngeal preservation, and survival in a 
large consecutive national cohort of patients with glottic 
squamous cell carcinomas (scc) treated with primary 
radiotherapy (RT) and salvage surgery over a period of 41 
years. 
 
Material and Methods: Patients diagnosed alive with a scc of 
the glottic larynx between 1971 and 2011 were included if 
curative treatment was started. Patients were identified 
from the DAHANCA database, and crosschecked with the 
National Cancer Registry. Missing information was obtained 
from hospitals records and the National Patient Registry. 
 
Results: A total of 5001 patients were identified. 98% of 
patients had primary RT. The median follow-up was 9.1 years 
(patients alive) and 5.7 years (patients who died). 10 patients 
were lost to follow-up. 1511 failures were observed; hereof 
93 %, 11 % and 5 % included T- and/or N- and/or M-site, 
respectively. 5-year incidence of local failure (LF) and loco-
regional failure (LRF) was 26 % and 27%, respectively. From 
the 1970s to the 2000s the 5-year incidence of LF and LRF 
decreased significantly; 32% vs 19% and 34% vs 21%, 
respectively. Curative salvage was intended in 1088/1511 
patients with failure, hereof 707 achieved ultimate control. 
In total, 980 patients had a laryngectomy, hereof 11 was 
primary treatment, 12 were caused by morbidity. The 5-year 
incidence of laryngectomy was 18%, decreasing from 26 % 
(1970s) to 10% (2000s). The 5-year incidence of ultimate 
failure was unchanged over time (range 13-16 %). 5-year 
estimates of laryngectomy free survival (LFS), Disease free 
survival(DFS) and Overall survival(OS) was 54%, 63% and 64%, 
respectively. LFS increased continuously, contrary to DFS and 
OS, which were stable in the 1970s-1990s but increased in the 
2000s. LFS, DFS and OS were significantly higher in the 00s 
compared to the earlier decades. 
 
Conclusion: As a result of a national strategy with primary 
RT, a continually improving disease control with concurrent 
decrease in laryngectomy, was observed in this non-selected 
national cohort of patients. All survival parameters were 
significantly better in the 2000s compared to the earlier 
decades. 
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Purpose or Objective: The aim of the study was to test the 
hypothesis that head and neck cancer (HNC) patients benefits 
from specialized follow-up (FU), as this strategy ensures 
timely detection of relapses for successful salvage treatment. 
This was done by evaluation of the pattern of failure, the 
temporal distribution of recurrences, and the outcome of 
salvage treatment in a contemporary cohort of HNC patients 
 
Material and Methods: The study evaluated a population 
based cohort of 2,062 consecutive patients treated with 
curative intent from 1 January 2000 to 31 December 2013. 
The database of DAHANCA contained recordings of recurrent 
disease in 567 patients with primary tumors of the larynx, 
pharynx, oral and nasal cavity, para-nasal sinuses and salivary 
glands. A review of medical records was performed in order 
to update and supplement the database.  
 
Results: Failures of the 567 patients were T-site failures 
(65%) followed by N-site (36%) and M-site (22%) failures. The 
vast majority of the first recurrence occurred within the first 
years after primary treatment; 62%, 82%, and 91% within the 
first, second and third year, respectively. Totally, 51% were 
amenable for salvage treatment, and 44% benefited from 
salvage in terms of a complete response. Permanent tumor 
control was observed in 128 patients (23%) after one or two 
salvage attempts. The highest salvage rate was recorded in 
patients with primary glottic carcinoma (41%) and the lowest 
among hypopharyngeal cancers (2%). Asymptomatic 
recurrence was recorded in 12% of all recurrences and this 
was found to be a positive prognostic factor for disease-
specific survival, as they had significantly better outcome 
after salvage.  
 
Conclusion: Our data support the usefulness of specialized 
FU in terms of early detection of recurrent disease. In 
particular patients with silent recurrences benefitted from 
early detection, as they had a significantly lower risk ratio of 
death from primary HNC.  
